Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.33 |
| ▸ | HPGD | P15428 | 11/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.33 |
| ▸ | MEN1 | O00255 | 9/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.33 |
| ▸ | LMNA | P02545 | 5/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 4/20 | 0.31 |
| ▸ | HTT | P42858 | 3/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25452095 | 0.85 | — | — | |
| SCHEMBL25458192 | 0.82 | — | — | |
| SCHEMBL24728513 | 0.81 | ALDH1A1 (0.36) | MAPTHPGDALDH1A1KMT2AMEN1 | |
| SCHEMBL17777674 | 0.80 | ALDH1A1 (0.39) | MAPTHPGDALDH1A1KMT2AMEN1 | |
| SCHEMBL24728353 | 0.80 | MEN1 (0.37) | MAPTHPGDALDH1A1KMT2AMEN1 | |
| SCHEMBL22679968 | 0.79 | HPGD (0.38) | MAPTHPGDALDH1A1KMT2AMEN1 | |
| SCHEMBL22799310 | 0.78 | SIRT2 (0.39) | KMT2AMEN1SYKPOLBNPSR1 | |
| SCHEMBL25452127 | 0.78 | SIGMAR1 (0.34) | MAPTKMT2AMEN1KDM4EGAA | |
| SCHEMBL24728445 | 0.78 | SIGMAR1 (0.34) | MAPTKMT2AMEN1KDM4EGAA | |
| SCHEMBL23959398 | 0.78 | MAPK14 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146030-A1 | ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE | OCIAD2, AOC2, OCIAD1 | MAPT 3021/4885HPGD 1997/4885ALDH1A1 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.